Safety and Efficacy Study of YZJ-1139 Tablets in Insomnia Disorder

by palligoelme@gmail.com | May 16, 2025 | Clinical Trials

​ Conditions: Insomnia Disorder Interventions: Drug: YZJ-1139; Drug: Zolpidem Sponsors: Shanghai Haiyan Pharmaceutical Technology Co., Ltd. Recruiting Conditions: Insomnia Disorder Interventions: Drug: YZJ-1139; Drug: Zolpidem Sponsors: Shanghai Haiyan Pharmaceutical...

Application and Effect of “Internet + Nursing” in Hip Fragility Fracture Patients Based on Fracture Liaison Service

by palligoelme@gmail.com | May 16, 2025 | Clinical Trials

​ Conditions: Fragility Fractures Interventions: Other: On the basis of routine nursing, the “Internet + nursing program” based on the FLS model is implemented Sponsors: The Fourth Affiliated Hospital of Zhejiang University School of Medicine...

Intravesical Chemotherapy in Combination With Systemic Pembrolizumab in NMIBC Unresponsive to BCG Therapy

by palligoelme@gmail.com | May 15, 2025 | Clinical Trials

​ Conditions: Non Muscle Invasive Bladder Cancer Interventions: Drug: intravesical Chemotherapy docetaxel/gemcitabine Sponsors: BLATAM Not yet recruiting Conditions: Non Muscle Invasive Bladder Cancer Interventions: Drug: intravesical Chemotherapy...

Upper GI MM vs Manometry

by palligoelme@gmail.com | May 15, 2025 | Clinical Trials

​ Conditions: GERD (Gastroesophageal Reflux Disease) Sponsors: Lexington Health Incorporated Completed Conditions: GERD (Gastroesophageal Reflux Disease) Sponsors: Lexington Health Incorporated Completed 

Phase II Study of Utidelone Plus Fruquintinib Combination Therapy for Platinum-Resistant Recurrent Ovarian Cancer

by palligoelme@gmail.com | May 15, 2025 | Clinical Trials

​ Conditions: Platinum Resistant Ovarian Cancer Interventions: Drug: Utidelone Capsules; Drug: Fruquintinib Capsules Sponsors: Fudan University Not yet recruiting Conditions: Platinum Resistant Ovarian Cancer Interventions: Drug: Utidelone Capsules; Drug: Fruquintinib...